The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConygar Inv Regulatory News (CIC)

Share Price Information for Conygar Inv (CIC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 78.00
Bid: 76.00
Ask: 80.00
Change: -0.50 (-0.64%)
Spread: 4.00 (5.263%)
Open: 78.50
High: 78.50
Low: 76.50
Prev. Close: 78.50
CIC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Related Party Transactions

22 Jan 2024 07:00

RNS Number : 3702A
Conygar Investment Company PLC(The)
22 January 2024
 

 

The Conygar Investment Company PLC

("Conygar", the "Company" or the "Group")

 

Related Party Transactions

 

As set out in the full year results on 21 November 2023, the Company, by way of its wholly owned subsidiary, Conygar Nottingham Limited is party to a services agreement (the "Agreement") with Larodde Limited ("Larodde"), in respect of The Island Quarter, Nottingham. The Company has agreed to extend the longstop date for assessing any potential fees payable to Larodde under the Agreement from 31 December 2023 to 30 June 2025. Larodde originally provided services to enable the acquisition of The Island Quarter and continues to provide additional services to further progress this development project. Larodde is wholly owned by Mr Miller-Cheevers, who is a director of the Company's subsidiary, Conygar Bristol Limited and therefore Larodde is a related party of the Company pursuant to the AIM Rules for Companies. 

 

Under the terms of the Agreement, Larodde is entitled to 10% of any surplus that either (i) an independent valuation of The Island Quarter as at 30 June 2025; or (ii) the net proceeds, if The Island Quarter is sold before that date, achieves over the total net costs of the project since acquisition, including a 7% priority return to Conygar. As set out in the 2023 Conygar Annual Report no amount was payable to Larodde under this Agreement as at 30 September 2023.

 

Furthermore, as notified in the announcement on 19 December 2023, Lavignac Securities Limited ("Lavignac") also receives fees from the Group to further progress both The Island Quarter Development in Nottingham and the proposed development of the land at St Philips Marsh, Bristol. Lavignac is also wholly owned by Mr Miller-Cheevers and therefore a related party of the Company pursuant to the AIM Rules for Companies. With effect from January 2024, the monthly fee payable to Lavignac has reduced from £16,667 to £15,000.

 

The extension of the Agreement and also the fees payable to Lavignac constitute related party transactions pursuant to AIM Rule 13. The Directors of Conygar consider, having consulted with Liberum, the Company's Nominated Adviser, that the terms of the transactions are fair and reasonable insofar as its shareholders are concerned.

 

 

Enquiries:

 

The Conygar Investment Company PLC

 

Robert Ware: 0207 258 8670

David Baldwin: 0207 258 8670

 

Liberum Capital Limited (Nominated Adviser and broker)

 

Richard Lindley: 0203 100 2222

Jamie Richards: 0203 100 2222

 

Temple Bar Advisory (public relations)

 

Alex Child-Villiers: 07795 425580

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBIGDBBDDDGSG
Date   Source Headline
16th Feb 20247:00 amRNSSubmission of Planning Application
29th Jan 20247:00 amRNSDirector/PDMR Shareholding
26th Jan 20249:11 amRNSDirector/PDMR Shareholding
22nd Jan 20247:00 amRNSRelated Party Transactions
16th Jan 20247:00 amRNSDirector/PDMR Shareholding
19th Dec 202312:00 pmRNSResults of Annual General Meeting
19th Dec 20237:00 amRNSRelated Party Transactions
14th Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSPRELIMINARY RESULTS
16th Nov 20237:00 amRNSNew Debt Facility
9th Nov 20237:00 amRNSNotification of Major Holdings
9th Nov 20237:00 amRNSNotification of Major Holdings
3rd Oct 20234:16 pmRNSPublication of ZDP Listing Document
2nd Oct 20238:00 amRNSResult of ZDP Issue
28th Sep 20237:00 amRNSLaunch of ZDP Issue
22nd Sep 20234:21 pmRNSHolding(s) in Company
31st May 20237:00 amRNSInterim Results
22nd May 20237:00 amRNSUpdate regarding ZDP Issue
18th May 20237:00 amRNSPlanning approved for bioscience development
5th May 20234:38 pmRNSExtension of ZDP Timetable
6th Apr 20231:48 pmRNSPotential Acquisition of Bristol Site
31st Mar 202312:30 pmRNSPublication of ZDP Prospectus
24th Mar 20234:07 pmRNSHaverfordwest – Completion of Sale
24th Mar 20237:00 amRNSFreeport status for Anglesey
20th Mar 20237:00 amRNSSale of Haverfordwest
28th Dec 20227:00 amRNSNEW DEBT FACILITIES AND PROPOSED ZDP ISSUE
19th Dec 202211:35 amRNSConygar - Results of AGM
2nd Dec 20227:00 amRNSPlanning Application for the Island Quarter
22nd Nov 20227:00 amRNSPreliminary Results
29th Jul 202210:23 amRNSDirector/PDMR Shareholding
5th Jul 20229:23 amRNSDirector/PDMR Shareholding
16th Jun 20222:49 pmRNSInvestigation of Debt Capital Options
25th May 202211:19 amRNSExclusivity extended at Bristol site
24th May 20227:00 amRNSResolution to grant planning
10th May 20227:00 amRNSInterim Results
28th Mar 202211:30 amRNSResult of General Meeting
3rd Mar 20225:22 pmRNSPosting of Circular and Notice of GM
10th Feb 20227:00 amRNSSale of Cross Hands Retail Park
4th Jan 202210:53 amRNSTotal Voting Rights
23rd Dec 20212:23 pmRNSTR-1: Notification of major holdings
22nd Dec 20213:21 pmRNSSale of Selly Oak Property
22nd Dec 202110:43 amRNSDirector/PDMR Shareholding
20th Dec 20215:04 pmRNSResult of AGM and Equity Raise update
17th Dec 20214:15 pmRNSResult of Placing
17th Dec 20217:00 amRNSProposed Placing
9th Dec 20217:00 amRNSPotential Development Acquisition in Bristol
29th Nov 20218:34 amRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSPreliminary Results
22nd Oct 20217:00 amRNSFurther planning application Holyhead Waterfront
1st Oct 20217:00 amRNSShare Buyback Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.